Although Gleason grading was recently updated to a grade group system [7], and is being used in combination with other established parameters, foremost tumor stage and prostate-specific antigen (PSA), current prognostication is insufficient and accurate risk-stratification remains difficult. This evidence concerns the gene KLK3 and neoplasm.